Literature DB >> 12691340

Use of botulinum toxin type A in management of adult spasticity--a European consensus statement.

Anthony B Ward1, Miguel Aguilar, Zegers De Beyl, Susanne Gedin, Petr Kanovsky, Franco Molteni, Jörg Wissel, Anton Yakovleff.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12691340     DOI： 10.1080/16501970306112

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN： 1650-1977            Impact factor:   2.912


× No keyword cloud information.
  6 in total

1.  [Botulinum toxin in the treatment of adult spasticity. An interdisciplinary German 10-point consensus 2010].

Authors:  J Wissel; M auf dem Brinke; M Hecht; C Herrmann; M Huber; S Mehnert; I Reuter; A Schramm; A Stenner; C van der Ven; M Winterholler; A Kupsch
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

Review 2.  Spasticity treatment with botulinum toxins.

Authors:  A B Ward
Journal:  J Neural Transm (Vienna)       Date:  2008-04-04       Impact factor: 3.575

Review 3.  The pharmacological management of post-stroke muscle spasticity.

Authors:  Abdel Magid O Bakheit
Journal:  Drugs Aging       Date:  2012-12       Impact factor: 3.923

Review 4.  Botulinum toxin in poststroke spasticity.

Authors:  Suheda Ozcakir; Koncuy Sivrioglu
Journal:  Clin Med Res       Date:  2007-06

5.  A systematic review protocol to evaluate the psychometric properties of measures of function within adult neuro-rehabilitation.

Authors:  Shannon Pike; Natasha Anne Lannin; Anne Cusick; Kylie Wales; Lynne Turner-Stokes; Stephen Ashford
Journal:  Syst Rev       Date:  2015-06-13

6.  A novel sensor-based assessment of lower limb spasticity in children with cerebral palsy.

Authors:  Seoyoung Choi; Yong Beom Shin; Soo-Yeon Kim; Jonghyun Kim
Journal:  J Neuroeng Rehabil       Date:  2018-06-04       Impact factor: 4.262
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.